维生素K的抗癌效应与肝细胞癌中的跨动脉化学栓塞相结合,这是一个随机对照试验
Yoshimichi Haruna1, Takayuki Yakushijin2,3, Miho Yamakawa3,4
1Department of Medical Affairs, Osaka Psychiatric Medical Center, Hirakata City, Osaka Prefecture, Japan. apple-123-grape@ab.auone-net.jp.
British journal of cancer
|April 22, 2025
概括
维生素K与跨动脉化学栓塞 (TACE) 结合,显著改善了肝细胞癌 (HCC) 患者的抗癌结果. 与单独TACE相比,这种组合治疗显示出更高的客观反应率和更长的无进展生存期,不增加不良事件.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 之前的研究表明,维生素K通过减少des-γ-carboxy prothrombin来增强索拉菲尼布在HCC中的抗癌作用.
- 这项研究调查了维生素K是否可以类似地增加跨动脉化学栓塞 (TACE) 在HCC治疗中的疗效.
研究的目的:
- 评估结合维生素K与TACE在无法切除的肝细胞癌 (HCC) 患者的疗效和安全性.
主要方法:
- 一项随机对照试验对不可切除的HCC患者进行了随机对照试验,这些患者被分配给TACE + 维生素K或单独TACE.
- 同主终点包括客观应答率和无进展生存期 (PFS);安全性是次要终点.
主要成果:
- 与TACE单独 (82.4%) 相比,TACE+维生素K组的客观响应率 (96.0%) 显著更高.
- 在TACE+维生素K组 (中位数262天) 与TACE单独 (中位数146天) 的无进展生存时间显著更长.
- 两组之间没有观察到不良事件发生率的显著差异.
结论:
- 与TACE单独治疗相比,与TACE结合的维生素K剂量为HCC患者提供了改善的抗癌结果.
- 组合疗法为无法切除的HCC提供了潜在的更有效的治疗策略.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.3K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
398
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
